Smerud Medical Research International AS
Smerud Medical Research International AS is recorded as a service provider in 5 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 5 of 5 trials · Latest update first
Open-label, safety, tolerability and proof of concept study to evaluate the use of ANXV (recombinant human Annexin A5 protein) in the treatment of patients with either Diabetic Retinopathy or recent onset Retinal Vein Occlusion
Sponsor Annexin Pharmaceuticals AB (publ)
- Start (EU)
- Latest update
- Estimated end
A phase 2B, multicenter, randomized, double-blind, placebo-controlled, dose-finding, efficacy and safety study of HRO350 in subjects with mild-to-moderate psoriasis (the ‘HeROPA’ study)
Sponsor Arctic Bioscience AS
- Start (EU)
- Latest update
- Estimated end
Trans-arterial treatment of patients with intra-hepatic cholangiocarcinoma not amenable to resection (TOMCAT)
Sponsor Oslo University Hospital HF
- Start (EU)
- Latest update
- Estimated end
- Not reported
Open-label, prospective study to assess the safety, tolerability, analgesic effect and feasibility of IN SUF/KET in pediatric patients with moderate or severe pain, in an acute care setting
Sponsor Cessatech A/S
- Start (EU)
- Latest update
- Estimated end
Randomised, double-blind study comparing the analgesic efficacy of a lidocaine-prilocaine combination with lidocaine alone as local anesthesia for dental procedures in participants with MC1R mutation
Sponsor Pharmavax AS
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Smerud Medical Research International AS?
The 2026-10-09 snapshot links Smerud Medical Research International AS to 5 distinct CTIS trials. Recorded services include Safety reporting & pharmacovigilance, Clinical monitoring, Data management, Project management, among 10 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Smerud Medical Research International AS?
Therapeutic-area tags are not recorded in this snapshot. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Smerud Medical Research International AS conducted?
The linked trials record locations in 5 countries, including Norway, Germany, Spain, Finland, Poland. These are trial locations, not confirmed office locations or countries where Smerud Medical Research International AS delivered services.
What can this page tell me about Smerud Medical Research International AS's trial experience?
Browse 5 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Smerud Medical Research International AS. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Smerud Medical Research International AS